CA 242 (tumor marker)
CA 242 is a tumor marker for sialylated Lewis carbohydrates associated with adenocarcinomas and e-selectin mediated metastatic risk.[1][2][3]
References
- ^ Louhimo J, Alfthan H, Stenman UH, Haglund C (2004). "Serum HCG beta and CA 72-4 are stronger prognostic factors than CEA, CA 19-9 and CA 242 in pancreatic cancer". Oncology 66 (2): 126–31. doi:10.1159/000077438. PMID 15138364. http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=OCL2004066002126.
- ^ Haglund C, Lundin J, Kuusela P, Roberts PJ (September 1994). "CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA". Br. J. Cancer 70 (3): 487–92. doi:10.1038/bjc.1994.332. PMC 2033366. PMID 8080735. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2033366.
- ^ Röthlin MA, Joller H, Largiadèr F (February 1993). "CA 242 is a new tumor marker for pancreatic cancer". Cancer 71 (3): 701–7. doi:10.1002/1097-0142(19930201)71:3<701::AID-CNCR2820710308>3.0.CO;2-C. PMID 8431849.
|
|
|
| Blood |
|
|
| Endocrine |
|
|
| Nervous system |
|
|
Cardiovascular/
respiratory |
|
|
| Digestive |
|
|
Reproductive/
urinary/
breast |
|
|
| General histology |
|
|
| Musculoskeletal |
|
|
|
|
|